GGrantIndex
Sort

23,748 grants matching melanoma

O-Glycosylation of Epidermal Growth Factor-like modules

$293,936
Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2007 · GM

O-Glycosylation of Epidermal Growth Factor-like modules

$293,936
Robert S. Haltiwanger · State University New York Stony Brook · R01 · FY2008 · GM

Multi-institutional analysis of multiplex immunofluorescence panels in tumor tissue specimens

$293,932
Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · CA

POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE

$293,931
Roswell Park Cancer Institute Corp · R01 · FY2001 · CA

Molecular Mechanisms of UVA apotosis and carcinogenesis

$293,917
University Of Arizona · P01 · FY2004 · CA

Core C: Cell Biology Core

$293,912
Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA

CELL MEDIATED IMMUNITY TO OCULAR TUMORS

$293,900
Schepens Eye Research Institute · R01 · FY2000 · EY

TREATMENT AND MOLECULAR ANALYSIS OF ATYPICAL NEVI

$293,852
University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA

Novel Single, Dual and Multitargeted Inhibitors of RTKs

$293,806
Duquesne University · R01 · FY2003 · CA

CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY

$293,771
Peter A Cohen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA

Targeted Molecular Therapeutics for Melanoma: CCI-779 and Bevacizumab

$293,721
Craig Lee Slingluff · University Of Virginia · R21 · FY2008 · CA

Targets of Immune-Mediated Tumor Destruction

$293,631
Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2009 · CA

Targets of Immune-Mediated Tumor Destruction

$293,631
Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2008 · CA

Targets of Immune-Mediated Tumor Destruction

$293,631
Glenn Dranoff · Dana-Farber Cancer Inst · R01 · FY2007 · CA

A Biobased Biodegradable Sunscreen that is Safe, Removes Environmental Impact, is Inclusive of all Skin Tones, and is for the Purpose of Eliminating Disparities in Melanoma Mortality Rates

$293,629
Andrew Cal · Olipha Inc · R41 · FY2024 · MD

Project 2 - PCG-1 Signaling and Mitochondrial Stress in Melanoma

$293,607
Marcus W Bosenberg · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2019 · CA

Core 3: Rexinoid Screening and Animal Core

$293,606
Mohammad Athar · University Of Alabama At Birmingham · P01 · FY2019 · CA

Molecular Classification of Primary Cutaneous Melanoma

$293,550
Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2009 · CA

Signal Transduction of GPR56

$293,550
Lei Xu · University Of Rochester · R01 · FY2015 · GM

Signal Transduction of GPR56

$293,550
Lei Xu · University Of Rochester · R01 · FY2014 · GM

Signal Transduction of GPR56

$293,550
Lei Xu · University Of Rochester · R01 · FY2012 · GM

PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS

$293,550
Peter A Cohen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA

Signal Transduction of GPR56

$293,550
Lei Xu · University Of Rochester · R01 · FY2016 · GM

Apoptosis in Melanoma Progression and Chemoresistance

$293,548
Maria S Soengas · University Of Michigan At Ann Arbor · R01 · FY2006 · CA

Regulation by the Immune Response to Vaccines by Botanicals

$293,521
Philip O. Livingston · Sloan-Kettering Inst Can Research · P50 · FY2009 · AT